Report cover image

Pharmaceutical Market Size - By Molecule Type, By Product, By Type, By Disease, By Route of Administration, By Age Group, By Distribution Channel - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Publisher SPER Market Research Pvt. Ltd.
Published Aug 21, 2025
Length 257 Pages
SKU # SPER20470242

Description

Pharmaceutical Market Introduction and Overview

According to SPER market research, ‘Global Pharmaceutical Market Size – By Molecule Type, By Product, By Type, By Disease, By Route of Administration, By Age Group, By Distribution Channel – Regional Outlook, Competitive Strategies and Segment Forecast to 2034’ state that the Global Pharmaceutical Market is predicted to reach 3054.67 billion by 2034 with a CAGR of 6.38%.

Drugs and treatments used to cure, prevent, or manage illnesses and medical problems are developed, produced, and sold as part of the pharmaceutical market. Vaccines, biologics, over-the-counter (OTC) medications, and prescription medications are all included. Innovation, aging populations, and the rise in chronic illnesses are driving the business, which is heavily regulated to guarantee efficacy and safety.

Restraints : The pharmaceutical industry is confronted with a number of significant obstacles in spite of its strong expansion. Long approval processes and regulatory obstacles can raise development costs and postpone product releases. When popular medications lose their exclusivity, patent cliffs cause revenue erosion and heightened competition from generics. Profitability is hampered by government and insurance pricing pressures, especially in cost-sensitive areas.

Scope of the report :

Report Metric Details
Market size available for years 2021-2034
Base year considered 2024
Forecast period 2025-2034

Segments covered : By Molecule Type, By Product, By Type, By Disease, By Route of Administration, By Age Group, By Distribution Channel

Regions covered : North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa

Companies Covered
AbbVie Inc., AstraZeneca, Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc., Johnson & Johnson Services, Inc., Merck & Co., Inc.,Novartis AG, Pfizer Inc., Sanofi

Global Pharmaceutical Market Segmentation :

By Molecule Type : Based on the Molecule Type, Global Pharmaceutical Market is segmented as; Biologics & Biosimilars (Large Molecules), Conventional Drugs (Small Molecules).

By Product : Based on the Product, Global Pharmaceutical Market is segmented as; Branded, Generic.

By Type : Based on the Type, Global Pharmaceutical Market is segmented as; Prescription, OTC.

By Disease : Based on the Disease, Global Pharmaceutical Market is segmented as; Cardiovascular diseases, Cancer, Diabetes, Infectious diseases, Neurological disorders, Respiratory diseases, Autoimmune diseases, Mental health disorders, Gastrointestinal disorders, Women’s health Diseases, Genetic and rare genetic diseases, Dermatological conditions, Obesity, Renal diseases, Liver conditions, Hematological disorders, Eye conditions, Infertility conditions, Endocrine disorders, Allergies, Others.

By Route of Administration : Based on the Route of Administration, Global Pharmaceutical Market is segmented as; Oral, Topical, Parenteral, Inhalations, Other.

By Age Group : Based on the Age Group, Global Pharmaceutical Market is segmented as; Children & Adolescents, Adults, Geriatric.

By Distribution Channel : Based on the Distribution Channel, Global Pharmaceutical Market is segmented as; Hospital Pharmacy, Retail Pharmacy, Others.

By Region : This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa.

Table of Contents

257 Pages
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPERs internal database
2.1.4. Premium insight from KOLs
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTERs Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Pharmaceutical Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Pharmaceutical Market
7. Global Pharmaceutical Market, By Molecule Type (USD Million) 2021-2034
7.1. Biologics & Biosimilars (Large Molecules)
7.2. Conventional Drugs (Small Molecules)
8. Global Pharmaceutical Market, By Product (USD Million) 2021-2034
8.1. Branded
8.2. Generic
9. Global Pharmaceutical Market, By Type (USD Million) 2021-2034
9.1. Prescription
9.2. OTC
10. Global Pharmaceutical Market, By Disease (USD Million) 2021-2034
10.1. Cardiovascular diseases
10.2. Cancer
10.3. Diabetes
10.4. Infectious diseases
10.5. Neurological disorders
10.6. Respiratory diseases
10.7. Autoimmune diseases
10.8. Mental health disorders
10.9. Gastrointestinal disorders
10.10. Womens health Diseases
10.11. Genetic and rare genetic diseases
10.12. Dermatological conditions
10.13. Obesity
10.14. Renal diseases
10.15. Liver conditions
10.16. Hematological disorders
10.17. Eye conditions
10.18. Infertility conditions
10.19. Endocrine disorders
10.20. Allergies
10.21. Others
11. Global Pharmaceutical Market, By Route of Administration (USD Million) 2021-2034
11.1. Oral
11.2. Topical
11.3. Parenteral
11.4. Inhalations
11.5. Other
12. Global Pharmaceutical Market, By Age Group (USD Million) 2021-2034
12.1. Children & Adolescents
12.2. Adults
12.3. Geriatric
13. Global Pharmaceutical Market, By Distribution Channel (USD Million) 2021-2034
13.1. Hospital Pharmacy
13.2. Retail Pharmacy
13.3. Others
14. Global Pharmaceutical Market (USD Million) 2021-2034
14.1. Global Pharmaceutical Market Size and Market Share
15. Global Pharmaceutical Market, By Region, (USD Million) 2021-2034
15.1. Asia-Pacific
15.1.1. Australia
15.1.2. China
15.1.3. India
15.1.4. Japan
15.1.5. South Korea
15.1.6. Rest of Asia-Pacific
15.2. Europe
15.2.1. France
15.2.2. Germany
15.2.3. Italy
15.2.4. Spain
15.2.5. United Kingdom
15.2.6. Rest of Europe
15.3. Middle East and Africa
15.3.1. Kingdom of Saudi Arabia
15.3.2. United Arab Emirates
15.3.3. Qatar
15.3.4. South Africa
15.3.5. Egypt
15.3.6. Morocco
15.3.7. Nigeria
15.3.8. Rest of Middle-East and Africa
15.4. North America
15.4.1. Canada
15.4.2. Mexico
15.4.3. United States
15.5. Latin America
15.5.1. Argentina
15.5.2. Brazil
15.5.3. Rest of Latin America
16. Company Profile
16.1. AbbVie Inc.
16.1.1. Company details
16.1.2. Financial outlook
16.1.3. Product summary
16.1.4. Recent developments
16.2. AstraZeneca
16.2.1. Company details
16.2.2. Financial outlook
16.2.3. Product summary
16.2.4. Recent developments
16.3. Bristol-Myers Squibb Company
16.3.1. Company details
16.3.2. Financial outlook
16.3.3. Product summary
16.3.4. Recent developments
16.4. F. Hoffmann-La Roche Ltd
16.4.1. Company details
16.4.2. Financial outlook
16.4.3. Product summary
16.4.4. Recent developments
16.5. GlaxoSmithKline plc.
16.5.1. Company details
16.5.2. Financial outlook
16.5.3. Product summary
16.5.4. Recent developments
16.6. Johnson & Johnson Services, Inc.
16.6.1. Company details
16.6.2. Financial outlook
16.6.3. Product summary
16.6.4. Recent developments
16.7. Merck & Co., Inc.
16.7.1. Company details
16.7.2. Financial outlook
16.7.3. Product summary
16.7.4. Recent developments
16.8. Novartis AG
16.8.1. Company details
16.8.2. Financial outlook
16.8.3. Product summary
16.8.4. Recent developments
16.9. Pfizer Inc.
16.9.1. Company details
16.9.2. Financial outlook
16.9.3. Product summary
16.9.4. Recent developments
16.10. Sanofi
16.10.1. Company details
16.10.2. Financial outlook
16.10.3. Product summary
16.10.4. Recent developments
16.11. Others
17. Conclusion
18. List of Abbreviations
19. Reference Links

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us